Billionaires John Paulson and D.E. Shaw Like This Stock

PAULSON & COAccording to 13F filings for the second quarter, D.E. Shaw increased its position in Mylan Inc (NASDAQ:MYL) by 19% between the beginning of April and the end of June to 16.9 million shares. Mylan, which develops and manufactures both generic and branded pharmaceutical products and ingredients, is also a favorite of billionaire John Paulson’s Paulson & Co. Paulson left its position in the company unchanged during the second quarter at 24.5 million shares. Paulson and D.E. Shaw have often increased and decreased their stakes in Mylan over the past several quarters, but at the end of June it was the fifth largest position in Paulson’s portfolio according to the fund’s 13F (see more stock picks from John Paulson and D.E. Shaw). So far this year Mylan is up 7%, underperforming the NASDAQ index, but it has risen an impressive 11% since the end of June.

The most common investment thesis behind Mylan is that as an increasing number of drugs go off-patent in the coming years, Mylan will be able to develop and sell generic equivalents. The vast majority of Mylan’s revenue is generated by generic drugs, though higher sales of its branded auto-injector for treating allergic reactions caused high growth in the branded segment. Overall, revenues increased 7% in the second quarter compared to the same period a year ago; earnings slightly decreased, but thanks to a fall in share count earnings per share were essentially unchanged. In the first half of 2012, Mylan saw a 7% increase in earnings, as revenue grew 9%, as well as the fall in share count. This drove its earnings per share up to 62 cents, compared to 56 cents in the first half of 2011.

Mylan’s second quarter report beat the Street’s earnings expectations, something the company had done in the previous three quarters as well. The beats have been narrow, but should give investors more confidence in the company’s ability to meet sell-side targets in the future. At the moment, analyst consensus is for earnings per share of $2.74 for 2013 and, with half the year in the books, $2.51 for 2012; this implies a 9% EPS growth rate next year, about in line with what it has done so far this year. The trend in patent expiration gives the company avenues to future growth, and Mylan has recently announced a partnership with Pfizer Inc (NYSE:PFE) to produce generic drugs for the Japanese market. The sell-side’s expectations imply a forward P/E of 9, which seems cheap, and going out further the five-year PEG ratio is 0.9.

The two closest peers for Mylan are Teva Pharmaceutical Industries Ltd (NYSE:TEVA) and Watson Pharmaceuticals Inc (NYSE:WPI). Both companies, similarly to Mylan, produce both generic and branded drugs. Teva is a monster value stock on a quantitative basis: it trades at 11 times trailing earnings, 7 times forward earnings estimates, and is coming off a 50% bump in earnings compared to the same period in the previous year. At a $35 billion market capitalization, it is also over three times Mylan’s size. Over the longer term, however, the sell-side has its growth coming in just under the smaller company’s and its five-year PEG ratio is 1. We still think it might be better to take the value and a 2.1% dividend yield now rather than trust the Street. Watson has high growth targets, with its earnings per share expected to increase 40% in 2013 compared to 2012; the forward P/E is 10, but this is higher than either of its peers we’ve discussed and depends on what looks to be quite a bit of optimism. Considering future growth prospects all three of these companies seem like good investments in the trend of generic pharmaceuticals. Mylan is certainly a good pick if investors believe that D.E. Shaw ‘s and Paulson’s positions outweigh the narrowly better value in quantitative terms at Teva.

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The Top 10 States With Fastest Internet Speeds

10 Best Places to Visit in USA in August

Top 10 Cities to Visit Before You Die

Top 10 Genetically Modified Food In the US

15 Highest Grossing Movies Opening Weekend

5 Best Poker Books For Beginners

10 Strategies Hedge Funds Use to Make Huge Returns

Top 10 Fast Food Franchises to Buy

10 Best Places to Visit in Canada

Best Summer Jobs for Teachers

10 Youngest Hedge Fund Billionaires

Top 10 One Hit Wonders of the 90s

Fastest Growing Cities In America

Top 10 U.S. Cities for Freelancers

Top 9 Most Popular Free iPhone Apps

Top 10 Least Expensive Private Business Schools in the US

Top 15 Most Expensive Countries in the World – 2014

Top Businesses to Invest In

Top 5 Things You Might Be Doing Wrong With Your Business

Top 5 Strategic Technology Trends in 2014

Top Rags to Riches Stories

Parenting Behavior That Promotes Future Leaders

Top 5 Mistakes Made by Small Businesses

Top 5 Most Common and Potentially Devastating Financial Blunders

Top 5 Highest Paying Jobs for Web Designers

Top 6 Most Respected Professions that Also Pay Well

Top 5 Pitfalls Investors Should Avoid

Top 6 Lawyers and Policy Makers Under 30

Top 6 New Year’s Resolutions for Entrepreneurs

Top 7 Locations to Check in on Facebook

Top 5 Mistakes made by Rookie eBay Sellers

Top 7 eBook Publishers in 2013

Top 6 Health Industry Trends in 2014

5 Lessons for Entrepreneurs from Seth Godin

Top 5 Success Tips from Jordan Belfort – the Wolf of Wall Street

Best Master’s in Finance Degree Programs

Top 6 Earning Celebrities Over 50

The most expensive sports to play

Top 7 Earning Celebrities Under 25

Best 7 Online Courses to Take: Free Finance MOOCs

Top 6 Bad Habits that Promote Failure

20 Most Valuable Soccer Teams in the World in 2013

12 Most Expensive Countries for Foreign Students

Top 30 Most Influential Women in the World

Top 20 Most Expensive New Year Eve Shows

Top 5 Best Vocational Careers

Top 10 Jobs for 2014 by Salary Gain (Predictions)

Top 5 Digital Trends for 2014

Top 6 Things You Can Do To Increase Your Productivity

Top 9 Trending Smartphones in 2013

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!